Industry Events
EnglishFrançaisEspañol中文العربية
活动新闻行业洞察主办方
服务
  • 活动营销向全球B2B受众发布、推广并拓展您的活动。
  • 新闻稿向全球行业专业人士分发官方公告。
  • 演讲者与专家推广展示您的专业知识,获得主旨演讲、专题讨论和大师班邀约。
订阅
演讲者登录免费发布您的活动
Industry Events

全球最值得信赖的B2B活动发现平台。将行业专业人士与重要的会议、展会和峰会连接起来。

  • Industry Events
  • 新闻
  • 活动主办方
  • 关于我们
  • 我们的服务
  • 高级主办方
  • Event Pro
  • 成为演讲者
  • 订阅
  • 使用条款
  • 隐私政策

© 2026 Industry Events Worldwide。保留所有权利。

VF96.7.
  • 活动
  • 新闻
  • 行业洞察
  • 账户
Industry Events
EnglishFrançaisEspañol中文العربية
活动新闻行业洞察主办方
服务
  • 活动营销向全球B2B受众发布、推广并拓展您的活动。
  • 新闻稿向全球行业专业人士分发官方公告。
  • 演讲者与专家推广展示您的专业知识,获得主旨演讲、专题讨论和大师班邀约。
订阅
演讲者登录免费发布您的活动
Industry Events

News

Categories

  • 最新
  • 中国与金砖国家+
  • 人工智能与科技
  • 供应链
  • 农业
  • 创业与风险投资
  • 医疗健康
  • 半导体
  • 国防
  • 机器人
  • 网络安全
  • 能源与出行
  • 金融科技

Select a category to explore the latest industry reporting.

NewsTuesday, 25 August 2026
Newsletter subscribe · Free
  • 最新
  • 人工智能与科技
  • 网络安全
  • 半导体
  • 机器人
  • 金融科技
  • 能源与出行
  • 国防
  • 医疗健康
  • 供应链
  • 创业与风险投资
  • 中国与金砖国家+
  • 农业

新闻

医疗健康

来自塑造行业的会议、展会和峰会的 医疗健康 领域最新新闻、公告和分析。

该分类的最新新闻

STAT+: Silence Therapeutics aims at Takeda with new data in rare blood cancer (opens original source in a new tab)
STAT News

STAT+: Silence Therapeutics aims at Takeda with new data in rare blood cancer

Industry Events

全球最值得信赖的B2B活动发现平台。将行业专业人士与重要的会议、展会和峰会连接起来。

A rare blood cancer drug from Silence Therapeutics showed strong results in a trial, potentially setting it up to compete with a Takeda medicine.

(opens original source in a new tab)
Jason Mast·10 August 2026
STAT+: China tightens the reins on clinical trials, even as the U.S. looks for ways to replicate its rival’s speed (opens original source in a new tab)
STAT News

STAT+: China tightens the reins on clinical trials, even as the U.S. looks for ways to replicate its rival’s speed

China has tightened regulations on investigator-initiated trials, with consequences not just for Chinese researchers but some Americans, too.

(opens original source in a new tab)
Brian Yang·10 August 2026
STAT+: A shortage of two Sanofi medicines for Pompe disease rattles patients (opens original source in a new tab)
STAT News

STAT+: A shortage of two Sanofi medicines for Pompe disease rattles patients

Sanofi is experiencing shortages of two medicines for Pompe disease, alarming patient groups.

(opens original source in a new tab)
Ed Silverman·10 August 2026
Opinion: Fauci doesn’t have the answers on Covid’s origins. China does (opens original source in a new tab)
STAT News

Opinion: Fauci doesn’t have the answers on Covid’s origins. China does

“To blame Fauci for not solving the origin of Covid-19 makes as much sense as blaming a detective in Washington, D.C., for not solving a murder in Wuhan,” writes David…

(opens original source in a new tab)
David J. Hunter·7 August 2026
STAT+: Up and down the ladder: The latest comings and goings (opens original source in a new tab)
STAT News

STAT+: Up and down the ladder: The latest comings and goings

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

(opens original source in a new tab)
Ed Silverman·7 August 2026
STAT+: NIH plans to block international researchers on visas from accessing key funding avenue (opens original source in a new tab)
STAT News

STAT+: NIH plans to block international researchers on visas from accessing key funding avenue

The NIH plans to close the door on one of the few pathways available to international students on visas to forge a career in biomedical research in the U.S.

(opens original source in a new tab)
Anil Oza·7 August 2026
STAT+: Pharmalittle: We’re reading about Replimune’s melanoma drug, a Medicare policy change, and more (opens original source in a new tab)
STAT News

STAT+: Pharmalittle: We’re reading about Replimune’s melanoma drug, a Medicare policy change, and more

Eli Lilly and Novo Nordisk convinced a federal judge to toss an antitrust lawsuit by a compound pharmacy

(opens original source in a new tab)
Ed Silverman·7 August 2026
Is the biotech capital of the world moving? (opens original source in a new tab)
STAT News

Is the biotech capital of the world moving?

Replimune finally wins FDA approval, the role of tau in Alzheimer's, and more biotech news from The Readout

(opens original source in a new tab)
Meghana Keshavan·7 August 2026
A third clinic settles with DOJ over trans care (opens original source in a new tab)
STAT News

A third clinic settles with DOJ over trans care

Anthony Fauci held in contempt, crackdowns on the organ donor network, and more health news from Morning Rounds

(opens original source in a new tab)
O. Rose Broderick·7 August 2026
STAT+: He grew up near Boston, went to Harvard, and worked at MIT. Why did he found his startup in California? (opens original source in a new tab)
STAT News

STAT+: He grew up near Boston, went to Harvard, and worked at MIT. Why did he found his startup in California?

Boston, with its rising costs, high taxes, and business climate, is losing ground to rivals across the country, sometimes even in biotech.

(opens original source in a new tab)
Emma Platoff — Boston Globe·7 August 2026
Opinion: AI won’t enhance physician autonomy. It will further diminish it (opens original source in a new tab)
STAT News

Opinion: AI won’t enhance physician autonomy. It will further diminish it

“AI is not the villain here; it is a mirror,” reflecting the diminishment of physician judgment, writes former surgeon Frances Mei Hardin.

(opens original source in a new tab)
Frances Mei Hardin·7 August 2026
Opinion: I was in my office when bullets hit the CDC. A year later, the agency remains under attack (opens original source in a new tab)
STAT News

Opinion: I was in my office when bullets hit the CDC. A year later, the agency remains under attack

“It was briefly more dangerous to sit at a desk in Atlanta than to chase a hemorrhagic fever in the field,” writes Daniel Jernigan.

(opens original source in a new tab)
Daniel Jernigan·7 August 2026

最多阅读

  1. 01

    STAT+: Silence Therapeutics aims at Takeda with new data in rare blood cancer

  2. 02

    STAT+: China tightens the reins on clinical trials, even as the U.S. looks for ways to replicate its rival’s speed

  3. 03

    STAT+: A shortage of two Sanofi medicines for Pompe disease rattles patients

  4. 04

    Opinion: Fauci doesn’t have the answers on Covid’s origins. China does

  5. 05

    STAT+: Up and down the ladder: The latest comings and goings

Prev
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
Next
  • Industry Events
  • 新闻
  • 活动主办方
  • 关于我们
  • 我们的服务
  • 高级主办方
  • Event Pro
  • 成为演讲者
  • 订阅
  • 使用条款
  • 隐私政策

© 2026 Industry Events Worldwide。保留所有权利。

VF96.7.

每周五送达的行业活动一周要闻。

一封简短的邮件。汇集塑造全球商业的展会、会议和峰会的头条新闻。没有废话,没有垃圾邮件,随时可取消订阅。